tradingkey.logo

Bio Rad Laboratories Inc

BIO
300.930USD
+1.070+0.36%
收盤 12/19, 16:00美東報價延遲15分鐘
8.12B總市值
虧損本益比TTM

Bio Rad Laboratories Inc

300.930
+1.070+0.36%

關於 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc簡介

公司代碼BIO
公司名稱Bio Rad Laboratories Inc
上市日期Mar 17, 1980
CEOSchwartz (Norman D)
員工數量7700
證券類型Ordinary Share
年結日Mar 17
公司地址1000 Alfred Nobel Dr
城市HERCULES
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編94547
電話15107247000
網址https://www.bio-rad.com/
公司代碼BIO
上市日期Mar 17, 1980
CEOSchwartz (Norman D)

Bio Rad Laboratories Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月30日 週日
更新時間: 11月30日 週日
持股股東
股東類型
持股股東
持股股東
佔比
First Eagle Investment Management, L.L.C.
11.50%
The Vanguard Group, Inc.
8.17%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
其他
59.06%
持股股東
持股股東
佔比
First Eagle Investment Management, L.L.C.
11.50%
The Vanguard Group, Inc.
8.17%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
其他
59.06%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
43.38%
Investment Advisor
40.44%
Individual Investor
8.25%
Corporation
8.13%
Hedge Fund
5.13%
Research Firm
1.16%
Bank and Trust
1.15%
Pension Fund
1.14%
Sovereign Wealth Fund
0.63%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
2023Q3
1170
19.31M
88.28%
-552.69K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
First Eagle Investment Management, L.L.C.
2.52M
11.45%
+223.05K
+9.72%
Jun 30, 2025
The Vanguard Group, Inc.
1.84M
8.38%
-59.61K
-3.13%
Jun 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.1%
--
--
May 01, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
7.02%
-98.58K
-6.00%
Jun 30, 2025
Schwartz (Norman D)
447.98K
2.04%
+5.20K
+1.17%
Sep 06, 2025
Dimensional Fund Advisors, L.P.
999.57K
4.55%
+122.53K
+13.97%
Jun 30, 2025
Veritas Asset Management LLP
863.14K
3.92%
-49.98K
-5.47%
Jun 30, 2025
Ariel Investments, LLC
818.62K
3.72%
+93.96K
+12.97%
Jun 30, 2025
EARNEST Partners, LLC
605.89K
2.75%
+6.26K
+1.04%
Jun 30, 2025
State Street Investment Management (US)
584.37K
2.66%
-110.15K
-15.86%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
查看更多
Parnassus Value Select ETF
佔比3.94%
First Trust Indxx Medical Devices ETF
佔比2.15%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.61%
Schwab Ariel Opportunities ETF
佔比1.6%
First Trust Health Care Alphadex Fund
佔比1.49%
FPA Global Equity ETF
佔比1.38%
First Eagle Global Equity ETF
佔比1.21%
iShares Health Innovation Active ETF
佔比1.17%
Pacer US Export Leaders ETF
佔比1.03%
Harbor Health Care ETF
佔比0.82%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Bio Rad Laboratories Inc的前五大股東是誰?

Bio Rad Laboratories Inc的前五大股東如下:
First Eagle Investment Management, L.L.C.
持有股份:2.52M
佔總股份比例:11.45%。
The Vanguard Group, Inc.
持有股份:1.84M
佔總股份比例:8.38%。
Alice N. Schwartz Revocable Trust
持有股份:1.78M
佔總股份比例:8.10%。
BlackRock Institutional Trust Company, N.A.
持有股份:1.54M
佔總股份比例:7.02%。
Schwartz (Norman D)
持有股份:447.98K
佔總股份比例:2.04%。

Bio Rad Laboratories Inc的前三大股東類型是什麼?

Bio Rad Laboratories Inc 的前三大股東類型分別是:
First Eagle Investment Management, L.L.C.
The Vanguard Group, Inc.
Alice N. Schwartz Revocable Trust

有多少機構持有Bio Rad Laboratories Inc(BIO)的股份?

截至2025Q4,共有1040家機構持有Bio Rad Laboratories Inc的股份,合計持有的股份價值約為20.58M,占公司總股份的101.60% 。與2025Q3相比,機構持股有所增加,增幅為-1.58%。

哪個業務部門對Bio Rad Laboratories Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Bio Rad Laboratories Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI